Epigenetic Regulation of miR-129-2 Leads to Overexpression of PDGFRa and FoxP1 in Glioma Cells.

Epigenetic Regulation of miR-129-2 Leads to Overexpression of PDGFRa and FoxP1 in Glioma Cells.
复制标题

miR-129-2 的表观遗传调控导致胶质瘤细胞中 PDGFRa 和 FoxP1 的过度表达。

DOI:
10.7314/apjcp.2015.16.14.6129
复制
发表时间:
2015
期刊:
Asian Pac J Cancer Prev
影响因子:
--
通讯作者:
Li, Ming
Li, Ming
中科院分区:
其他
文献类型:
--
作者:
Tian, Xiang-Yang;Zhang, Ling;Sun, Lai-Guang;Li, Ming

文献摘要

参考文献

相似文献

miR-129-2在多种癌症中经常下调。然而,它是如何在癌症中消失的仍不清楚。在这里,我们研究了miR-129-2在胶质母细胞瘤(GBM)中的表达谱和潜在的生物学功能,胶质母细胞瘤是成人中最常见和致命的脑肿瘤。我们发现miR-129-2在GBM患者标本和培养细胞系中丢失。组蛋白去乙酰化酶抑制剂(trichostatin a)可恢复miR-129-2的表达,但DNA甲基化抑制剂(5-Aza-2'-脱氧胞苷)不能恢复miR-129-2的表达,两种药物联合治疗效果更显著。此外,miR-129-2的强制表达抑制了GBMs中PDGFRa和Foxp1等主要致癌基因的表达。同样,miR-129-2的表达在体外显著抑制GBM细胞的增殖。这些结果表明,miR-129-2在GBM中受表观遗传调控,并作为肿瘤抑制基因发挥作用,提示其可能作为GBM治疗的潜在治疗靶点。
miR-129-2 is frequently downregulated in multiple cancers. However, how it is silenced in cancers remains unclear. Here we investigated the expression profile and potential biological function of miR-129-2 in glioblastoma (GBM), the most common and lethal form of brain tumors in adults. We showed that miR-129-2 is lost in GBM patient specimens and cultured cell lines. miR-129-2 expression could be restored upon treatment with a histone deadetylase inhibitor (trichostatin A) but not a DNA methylation inhibitor (5-Aza-2'-deoxycytidine), and more profound effect was observed with the treatment of these two drugs in combination. Furthermore, forced expression of miR-129-2 repressed the expression of major oncogenic genes such as PDGFRa and Foxp1 in GBMs. Consistently, expression of miR-129-2 significantly inhibits GBM cell proliferation in vitro. These results reveal that miR-129-2 is epigenetically regulated and functions as a tumor suppressor gene in GBMs, suggesting it may serve as a potential therapeutic target for GBM treatment.
DOI: 10.1158/0008-5472.can-09-1499
发表时间: 2009-12-01
期刊: Cancer research
影响因子: 11.2
作者:
Huang YW;Liu JC;Deatherage DE;Luo J;Mutch DG;Goodfellow PJ;Miller DS;Huang TH
通讯作者: Huang TH
DOI: 10.2147/ott.s65548
发表时间: 2014
影响因子: 4
作者:
Fesler A;Zhai H;Ju J
通讯作者: Ju J
DOI: 10.1158/0008-5472.can-13-2117
发表时间: 2014-03-01
期刊: Cancer research
影响因子: 11.2
作者:
Gomez GG;Volinia S;Croce CM;Zanca C;Li M;Emnett R;Gutmann DH;Brennan CW;Furnari FB;Cavenee WK
通讯作者: Cavenee WK
DOI: 10.1038/ncb2024
发表时间: 2010-03
影响因子: 21.3
作者:
Ma, Li;Young, Jennifer;Prabhala, Harsha;Pan, Elizabeth;Mestdagh, Pieter;Muth, Daniel;Teruya-Feldstein, Julie;Reinhardt, Ferenc;Onder, Tamer T.;Valastyan, Scott;Westermann, Frank;Speleman, Frank;Vandesompele, Jo;Weinberg, Robert A.
通讯作者: Weinberg, Robert A.
DOI: 10.1038/cddis.2013.193
发表时间: 2013-06-06
影响因子: 9
作者:
通讯作者: --